TipRanks
Kyongbo Pharmaceutical Co., Ltd. (KR:214390)
:214390
South Korea Market
214390
Kyongbo Pharmaceutical Co., Ltd.
RESEARCH TOOLSreports

Kyongbo Pharmaceutical Co., Ltd. (214390) Revenue

― Followers
StatisticsMarket CapRevenue

Kyongbo Pharmaceutical Co., Ltd. Revenue

Kyongbo Pharmaceutical Co., Ltd. had a revenue of 75.22B in the quarter ending Jun 30, 2026, with 13.75%. This bring the company's revenue in the last twelve months to 279.55B, Decreased 3.68%. In the fiscal year ending Dec 31, 2025, Kyongbo Pharmaceutical Co., Ltd. had annual revenue of 264.10B with 10.71% growth.
Revenue (ttm)
279.55B
Revenue Growth
14.83%
P/S Ratio
0.50
Revenue/Employee
₩522,978,331
Employees
505
Market Cap
₩131.49B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
264.10B25.55B+10.71%
Dec 31, 2024
238.56B22.20B+10.26%
Dec 31, 2023
216.36B20.09B+10.24%
Dec 31, 2022
196.26B25.61B+15.00%
Dec 31, 2021
170.66B-44.63B-20.73%
Dec 31, 2020
215.29B23.58B+12.30%
Dec 31, 2019
191.71B-9.64B-4.79%
Dec 31, 2018
201.34B9.68B+5.05%
Dec 31, 2017
191.66B――